Akebia Therapeutics, Inc. (AKBA)
1.585
0.00 (0.00%)
USD |
NASDAQ |
Dec 10, 12:12
Akebia Therapeutics Total Assets (Quarterly): 364.15M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Pfizer Inc. | 208.73B |
| Plus Therapeutics, Inc. | 18.67M |
| Ironwood Pharmaceuticals, Inc. | 396.06M |
| Pyxis Oncology, Inc. | 105.60M |
| Karyopharm Therapeutics, Inc. | 96.23M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 322.56M |
| Shareholders Equity (Quarterly) | 41.59M |
| Debt to Equity Ratio | 5.128 |
| Current Ratio | 1.937 |
| Net Debt Paydown Yield | -3.00% |